Items where Author is "Joerger, Markus"
Number of items: 7. 2021Herbrand, Amanda Katherina and Schmitt, Andreas M. and Briel, Matthias and Ewald, Hannah and Goldkuhle, Marius and Diem, Stefan and Hoogkamer, Anouk and Joerger, Markus and Moffa, Giusi and Novak, Urban and Hemkens, Lars G. and Kasenda, Benjamin. (2021) Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. Jama Network Open, 4 (3). e210380. 2019Herbrand, Amanda Katherina and Schmitt, Andreas Michael and Briel, Matthias and Diem, Stefan and Ewald, Hannah and Hoogkamer, Anouk and Joerger, Markus and Mc Cord, Kimberly Alba and Novak, Urban and Sricharoenchai, Sirintip and Hemkens, Lars G. and Kasenda, Benjamin. (2019) Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. ESMO open, 4 (6). e000596. 2017Parra-Guillen, Zinnia P. and Berger, Peter B. and Haschke, Manuel and Donzelli, Massimiliano and Winogradova, Daria and Pfister, Bogumila and Früh, Martin and Gillessen, Silke and Krähenbühl, Stephan and Kloft, Charlotte and Joerger, Markus. (2017) Role of Cytochrome P450 3A4 and 1A2 Phenotyping in Patients with Advanced Non-small-Cell Lung Cancer Receiving Erlotinib Treatment. Basic and Clinical Pharmacology and Toxicology, 121 (4). pp. 309-315. 2012Matter-Walstra, Klazien and Joerger, Markus and Kühnel, Ursula and Szucs, Thomas and Pestalozzi, Bernhard and Schwenkglenks, Matthias. (2012) Cost-effectiveness of maintenance pemetrexed in patients with advanced nonsquamous-cell lung cancer from the perspective of the swiss health care system. Value in health, Vol. 15, H. 1. pp. 65-71. 2011Joerger, Markus and Matter-Walstra, Klazien and Früh, Martin and Kühnel, Ursula and Szucs, Thomas D. and Pestalozzi, Bernhard and Schwenkglenks, Matthias. (2011) Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis. Annals of oncology, 22 (3). pp. 567-574. Adamina, Michel and Joerger, Markus. (2011) Dose-toxicity models in oncology. Expert Opinion on Drug Metabolism & Toxicology, Vol. 7, H. 2. pp. 201-211. 2009Joerger, Markus and Thürlimann, Beat. (2009) Update of the BIG 1-98 Trial : where do we stand? The breast : official journal of the European Society of Mastology, Vol. 18 , S78-82. |
